GT Biopharma Inc. Common Stock

$0.4081

-0.0119 (-2.83%)

Volume:

539.197K ($225.73K)

#2411 Volume #4321 Dollar Volume

Market Capitalization:

$12.88M

#4954 Market Cap

GT Biopharma Price Chart

GT Biopharma Volume Chart

GT Biopharma Market Segments

After Hours

-0.0058(-1.40%)

Open	$0.4139
Close	$0.4081
Low	$0.4081
Low Change	-0.0058 (-1.40%)
High	$0.4199
High Change	+0.0060 (+1.45%)
Range	$0.0118
Volume	8.75K
Dollar Volume	$3.57K

Regular Trading Hours

-0.0278(-6.24%)

Open	$0.4455
Close	$0.4177
Low	$0.4100
Low Change	-0.0355 (-7.97%)
High	$0.4455
High Change	+0.0000 (+0.00%)
Range	$0.0355
Volume	512.264K
Dollar Volume	$213.97K

Premarket

+0.0250(+5.88%)

Open	$0.4250
Close	$0.4500
Low	$0.4190
Low Change	-0.0060 (-1.41%)
High	$0.4500
High Change	+0.0250 (+5.88%)
Range	$0.0310
Volume	18.183K
Dollar Volume	$8.18K

After Hours Yesterday

+0.0045(+1.08%)

Open	$0.4177
Close	$0.4222
Low	$0.4175
Low Change	-0.0002 (-0.05%)
High	$0.4309
High Change	+0.0132 (+3.16%)
Range	$0.0134
Volume	12.19K
Dollar Volume	$5.15K

Regular Trading Hours Yesterday

-0.0110(-2.55%)

Open	$0.4310
Close	$0.4200
Low	$0.4100
Low Change	-0.0210 (-4.87%)
High	$0.4399
High Change	+0.0089 (+2.06%)
Range	$0.0299
Volume	533.968K
Dollar Volume	$224.27K

Premarket Yesterday

-0.0025(-0.59%)

Open	$0.4226
Close	$0.4201
Low	$0.4201
Low Change	-0.0025 (-0.59%)
High	$0.4226
High Change	+0.0000 (+0.00%)
Range	$0.0025
Volume	800
Dollar Volume	$336.08

GT Biopharma Moving Averages

5 Day Moving Average (SMA5)	$0.4321
10 Day Moving Average (SMA10)	$0.4460
20 Day Moving Average (SMA20)	$0.4529
50 Day Moving Average (SMA50)	$0.5827
100 Day Moving Average (SMA100)	$0.6420
200 Day Moving Average (SMA200)	$1.2212

GT Biopharma Statistics

Average Volume (30 Days)	1.22M
P/E Ratio (Current)	-.34
EPS (Current)	-$1.29
Dividend Yield	1.23%
Free Cash Flow	—
Cash Ratio	2.94
Current Ratio	3.45
Quick Ratio	3.45
Debt to Equity	0.00
Enterprise Value	$4.92M
EV to EBITDA	-0.40
EV to Sales	—
Price to Book	2.03
Price to Cash Flow	—
Price to Free Cash Flow	—
Price to Sales	—
Return on Assets	-4.25%
Return on Equity	-5.95%

GT Biopharma Stock Splits

There have been 2 stock splits for GT Biopharma (GTBP). The last reverse stock split occured on February 5, 2024 and reduced the outstanding shares at a ratio of 30:1.

Date	Type	Ratio
Feb 5, 2024	Reverse	30:1
Feb 11, 2021	Reverse	17:1

GT Biopharma Dividends

There have been no dividends for GT Biopharma (GTBP).